ApoB in sdLDL is shown to be preferentially glycated (in vitro and in vivo) compared with lbLDL and a higher percentage is glycated in T2DM (14.8%) compared with non-diabetics (4.8%). The gene discussed is APOB; the disease is type 2 diabetes mellitus.